Barriers to access to antihypertensive medicines: insights from the HEARTS initiative in latin American and Caribbean region
The barriers to accessing essential antihypertensive medications in Latin America and the Caribbean are multifaceted, stemming from outmoded NEMLs, limited market availability of advised medications, and disparate procurement processes. Leveraging pooled procurement mechanisms such as the PAHO Strategic Fund, coupled with vital updates to NEMLs, stands to markedly improve both the accessibility and affordability of these treatments.
Authors
- Juliana Vallini
- Kathiaja Miranda Souza (ORCID: https://orcid.org/0000-0002-9054-4794)
- Andrés Rosende (ORCID: https://orcid.org/0000-0001-8173-0686)
- Nora Girón
- Pedro Ordúñez (ORCID: https://orcid.org/0000-0002-9871-6845)
- Kemel Hallar
- Baudelio Ramírez Loya
- Christoper Lim
- David Debrott Sánchez
Institutions
- World Health Organization Regional Office for the Americas (US)
- Pan American Health Organization (Cuba) (CU)
- Universidad Panamericana (MX)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1080/20523211.2024.2379045
- Citations
- 9
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 10.16
Funders
- Universidad Nacional de La Plata
- Pan American Health Organization